Champlain Investment Partners Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Veralto
VLTO
|
+$139M |
| 2 |
e.l.f. Beauty
ELF
|
+$133M |
| 3 |
Monster Beverage
MNST
|
+$123M |
| 4 |
Lincoln Electric
LECO
|
+$118M |
| 5 |
Mine Safety
MSA
|
+$116M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AXON
Axon Enterprise
AXON
|
+$277M |
| 2 |
Align Technology
ALGN
|
+$136M |
| 3 |
Toast
TOST
|
+$119M |
| 4 |
Ametek
AME
|
+$114M |
| 5 |
Dentsply Sirona
XRAY
|
+$109M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.81% |
| 2 | Healthcare | 20.27% |
| 3 | Industrials | 18.52% |
| 4 | Financials | 14.49% |
| 5 | Consumer Staples | 14.03% |
Similar funds
Champlain Investment Partners's Q4 2024 Portfolio in Review
As of Q4 2024, Champlain Investment Partners held 140 positions worth $15.8B, down 4.5% from $16.5B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Champlain Investment Partners withdrew a net $1.12B in Q4 2024, closing 7 positions and reducing 87 holdings. Its most notable exit was Align Technology, an estimated $136M position sold in full.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 25% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Champlain Investment Partners opened a new position in Veralto worth $133M.
- Champlain Investment Partners's largest Q4 2024 buy was Veralto: 1,306,410 shares worth $133M.
- Champlain Investment Partners added most to e.l.f. Beauty in Q4 2024, an estimated $133M increase.
- Champlain Investment Partners's biggest Q4 2024 reduction was Axon Enterprise, cutting an estimated $277M.
- Champlain Investment Partners fully exited Align Technology in Q4 2024, selling an estimated $136M.
- Champlain Investment Partners's ten largest holdings make up 19% of its $15.8B portfolio in Q4 2024.
- Champlain Investment Partners opened 16 new positions and closed 7 in Q4 2024.
- Champlain Investment Partners's portfolio value fell 4.5% quarter-over-quarter to $15.8B.
Based on Champlain Investment Partners's 13F filing for Q4 2024, filed 13 Feb 2025.